|
|
|
|
|
Miranda Bellezza, Azzurra di Palma and Andrea Frosini
Alzheimer?s disease (AD) is a neurodegenerative disorder that leads to the loss of cognitive functions due to the deterioration of brain tissue. Current diagnostic methods are often invasive or costly, limiting their widespread use. Developing non-invasi...
ver más
|
|
|
|
|
|
|
|
|
|
|
Md Easin Hasan and Amy Wagler
Neuroimaging experts in biotech industries can benefit from using cutting-edge artificial intelligence techniques for Alzheimer?s disease (AD)- and dementia-stage prediction, even though it is difficult to anticipate the precise stage of dementia and AD....
ver más
|
|
|
|
|
|
|
|
|
|
|
Pratham Grover, Kunal Chaturvedi, Xing Zi, Amit Saxena, Shiv Prakash, Tony Jan and Mukesh Prasad
Alzheimer?s disease is a chronic neurodegenerative disease that causes brain cells to degenerate, resulting in decreased physical and mental abilities and, in severe cases, permanent memory loss. It is considered as the most common and fatal form of deme...
ver más
|
|
|
|
|
|
|
|
|
|
|
Zhiqiong Wang, Zican Lin, Shuo Li, Yibo Wang, Weiying Zhong, Xinlei Wang and Junchang Xin
Alzheimer?s disease (AD) is a progressive, irreversible neurodegenerative disorder that requires early diagnosis for timely treatment. Functional magnetic resonance imaging (fMRI) is a non-invasive neuroimaging technique for detecting brain activity. To ...
ver más
|
|
|
|
|
|
|
|
|
|
|
Nayef Alqahtani, Shadab Alam, Ibrahim Aqeel, Mohammed Shuaib, Ibrahim Mohsen Khormi, Surbhi Bhatia Khan and Areej A. Malibari
Dementias that develop in older people test the limits of modern medicine. As far as dementia in older people goes, Alzheimer?s disease (AD) is by far the most prevalent form. For over fifty years, medical and exclusion criteria were used to diagnose AD,...
ver más
|
|
|
|
|
|
|
|
|
|
|
Xiaoli Yang, Yuxin Xia, Zhenwei Li, Lipei Liu, Zhipeng Fan and Jiayi Zhou
Alzheimer?s disease (AD) is one of the most common irreversible brain diseases in the elderly. Mild cognitive impairment (MCI) is an early symptom of AD, and the early intervention of MCI may slow down the progress of AD. However, due to the subtle neuro...
ver más
|
|
|
|
|
|
|
|
|
|
|
Zeyuan Zhao, Ping Li, Yongjie Dai, Zhaoe Min and Lei Chen
Alzheimer?s disease (AD) is an irreversible neurodegenerative disease. Providing trustworthy AD progression predictions for at-risk individuals contributes to early identification of AD patients and holds significant value in discovering effective treatm...
ver más
|
|
|
|
|
|
|
|
|
|
|
Fan Zhang, Melissa Petersen, Leigh Johnson, James Hall, Raymond F. Palmer, Sid E. O?Bryant and on behalf of the Health and Aging Brain Study (HABS?HD) Study Team
The Health and Aging Brain Study?Health Disparities (HABS?HD) project seeks to understand the biological, social, and environmental factors that impact brain aging among diverse communities. A common issue for HABS?HD is missing data. It is impossible to...
ver más
|
|
|
|
|
|
|
|
|
|
|
Zhaoyi Chen, Yuchen Yang, Dazheng Zhang, Jingchuan Guo, Yi Guo, Xia Hu, Yong Chen and Jiang Bian
Alzheimer?s disease (AD) and AD-related dementias (AD/ADRD) are a group of progressive neurodegenerative diseases. The progression of AD can be conceptualized as a continuum in which patients progress from normal cognition to preclinical AD (i.e., no sym...
ver más
|
|
|
|
|
|
|
|
|
|
|
You Sheng Toh and Carol Anne Hargreaves
Extensive medical research has revealed evidence of a strong association between hippocampus atrophy and age-related diseases such as Alzheimer?s disease (AD). Therefore; segmentation of the hippocampus is an important task that can help clinicians and r...
ver más
|
|
|
|
|
|